Brain cancer keeps popping up in the news for the wrong reasons. Last week, it took the life of Gord Downie, lead singer of the Canadian rock band The Tragically Hip. Sen. John McCain, who was diagnosed in July, recently acknowledged his prognosis is “very poor.”

But there are dozens of experimental therapies for glioblastoma in the works — and on Friday, the San Diego biotech company Tocagen (TOCA) reported some hopeful, though very early, news on one novel approach.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy